title: In vivo effect of immobilisation of bone morphogenic protein 2 on titanium implants through nano-anchored oligonucleotides.
abstract: The aim of the present study was to test the hypothesis that immobilisation of bone morphogenic proteins on the surface of titanium implants through nano-anchored oligonucleotides can enhance peri-implant bone formation. Non-coding 60-mer DNA oligonucleotides (ODN) were anchored to the surface of custom made sandblasted acid etched (SAE) titanium screw implants through anodic polarisation, gamma-sterilised with a standard dose of 25 kGy, and were hybridised with complementary 30-mer strands of DNA oligonucleotides conjugated to rhBMP2. Blank SAE implants, SAE implants with nano-anchored ODN and SAE implants with nano-anchored ODN and non-conjugated rhBMP2 served as controls. The implants were inserted into the tibiae of 36 Sprague Dawley rats. Perforations at the head and the tip of the implants allowed for bone ingrowth. Bone ingrowth into perforations and bone implant contact (BIC) as well as bone density (BD) at a distance of 200 µm from the implant surface were assessed after 1 , 4 and 13 weeks. Implants with nano-anchored ODN strands hybridised with conjugated rhBMP2 exhibited enhanced bone ingrowth into the perforations and increased BIC after 1 week as well as increased BIC after 4 weeks compared to controls. No difference was seen after 13 weeks. Bone density around the outer implant surface did not differ significantly at any of the intervals. It is concluded that rhBMP2 immobilised on the surface of titanium implants through nano-anchored oligonucleotide strands can enhance bone implant contact. The conditions of sterilisation tested allowed for handling under clinically relevant conditions.
authors.affiliation: Dept. of Oral and Maxillofacial Surgery, George-Augusta-University, Robert-Koch-Str 40, 37075 Göttingen, Germany.schliephake.henning@med.uni-goettingen.de.
authors.forename: H
authors.initials: H
authors.lastname: Schliephake
authors.forename: J
authors.initials: J
authors.lastname: Rublack
authors.forename: N
authors.initials: N
authors.lastname: Aeckerle
authors.forename: A
authors.initials: A
authors.lastname: Förster
authors.forename: B
authors.initials: B
authors.lastname: Schwenzer
authors.forename: J
authors.initials: J
authors.lastname: Reichert
authors.forename: D
authors.initials: D
authors.lastname: Scharnweber
mesh_terms: D000818:Animals; D015519:Bone Density / Q000187:drug effects; D055396:Bone Morphogenetic Protein 2 / Q000378:metabolism*; D001863:Bone Screws; D001842:Bone and Bones / Q000601:surgery; D020099:Coated Materials, Biocompatible / Q000494:pharmacology; D009841:Oligonucleotides / Q000378:metabolism*; D010012:Osteogenesis / Q000187:drug effects*; D017207:Rats, Sprague-Dawley; D014025:Titanium / Q000494:pharmacology*
chemical_list: D055396:Bone Morphogenetic Protein 2; D020099:Coated Materials, Biocompatible; D009841:Oligonucleotides; D014025:Titanium